Join us as we talk with Dr. Saad Usmani, MD about his new position as Director of Clinical Research for Hematologic Malignancies and Director of Plasma Cell Disorders at the Levine Cancer Institute and his clinical trials for high-risk myeloma patients. Dr. Usmani was formerly at UAMS.

Hear from Dr. Brendan Weiss, MD from the Abramson Cancer Center at the University of Pennsylvania about the indicators and factors that can MGUS progression to myeloma and a host of immunotherapy approaches that are up-and-coming both in the lab and clinic. He will also share his work on the bone marrow environment, how obesity impacts transplant, and how MGUS in racial groups.

Join us as we talk in detail about the recent announcement by the Mayo Clinic on Dr. Stephen Russell, MD, PhD's success in using the measles vaccine to halt myeloma growth. This major announcement was made earlier this week and patients want to know more. Dr. Russell will describe the long road to use vaccines to treat cancer, how that work was connected to myeloma, how it works in myeloma, and what comes next.

Join us as we talk with Dr. Paul Richardson about why and when patients should join a multiple myeloma clinical trial. As a leader in very large myeloma clinical trials, Dr. Richardson will share studies that are moving the bar in myeloma care.

Join us as we talk Dr. Pieter Sonneveld, MD, PhD, who is the Chairman of the European Myeloma Network and Chairman of the HOVON Foundation about advances in myeloma in Europe and throughout the world.

Join us as we talk with myeloma genetics expert Dr. Walter Kuehl, MD, PhD of the National Cancer Institute about the progress being made in segmenting and targeting specific approaches for myeloma. Dr. Kuehl has completed deep research on the various pathways affected by these myeloma "subtypes."

Join us as we speak with Dr. Vincent Rajkumar, MD of the Mayo Clinic about obesity and race in multiple myeloma.

Join us as we talk with Dr. Jonathan Licht of the Robert H. Lurie Comprehensive Cancer Center and Northwestern University about high risk myeloma.

Join us as we talk with Dr. Aaron Rapoport, MD of the University of Maryland Greenbaum Cancer Center about his vaccine approaches and T-cell research in myeloma.

Join us as we talk with Dr. Robert Z. Orlowski, MD, PhD of MD Anderson Cancer about immunotherapies and the latest in his myeloma research.